PMID: 6106781Sep 27, 1980Paper

Prevention of isophosphamide-induced urothelial toxicity with 2-mercaptoethane sulphonate sodium (mesnum) in patients with advanced carcinoma

Lancet
B M BryantI Smith

Abstract

In 8 patients receiving intravenous isophosphamide 2 g/m2 at 2-week intervals for advanced bronchogenic carcinoma the protective effect of 2-mercaptoethane sulphonate sodium (mesnum) against isophosphamide-induced urothelial toxicity was tested in a single-blind crossover trial. With isophosphamide alone, 7 of the 8 patients developed either haematuria or symptoms of bladder irritation; when mesnum was given in addition, only 1 patient had microhaematuria and frequency, and this was in association with a urinary-tract infection. 5 patients then received fifteen courses of isophosphamide in increasing doses of 4 to 8 g/m2 i.v. with mesnum. In contrast to previous experience with isophosphamide at this high dosage, frank haematuria was never seen, microhaematuria was seen after only three courses, and mild dysuria after only one course. Pharmacokinetic studies showed that mesnum did not interfere with the metabolism of isophosphoramide or its active anti-tumour metabolite, isophosphoramide mustard. Mesnum therefore enhances the therapeutic ratio of isophosphamide and may thereby increase its clinical efficacy.

References


❮ Previous
Next ❯

Citations

Jan 1, 1982·Cancer Chemotherapy and Pharmacology·S B Kaye
Jan 1, 1982·Cancer Chemotherapy and Pharmacology·G FalksonH C Falkson
Nov 1, 1994·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·F M Muggia
Jan 1, 1988·Journal of Cancer Research and Clinical Oncology·G G StegerK Moser
Jan 1, 1986·Cancer Chemotherapy and Pharmacology·N ThatcherA Rahman
Jan 1, 1986·Cancer Chemotherapy and Pharmacology·L H Einhorn, P J Loehrer
Jan 1, 1990·Cancer Chemotherapy and Pharmacology·F Sanchiz, A Milla
Jan 1, 1992·Cancer Chemotherapy and Pharmacology·T A WiklundI Elomaa
Jan 1, 1989·Cancer Chemotherapy and Pharmacology·M J LindP M Wilkinson
Jan 1, 1991·Journal of Cancer Research and Clinical Oncology·J A RadfordN Thatcher
Mar 30, 1995·International Journal of Radiation Oncology, Biology, Physics·L B MarksM S Anscher
Jan 1, 1992·Toxicology in Vitro : an International Journal Published in Association with BIBRA·J Ghaida, H J Merker
Mar 6, 1982·Lancet·E C Gordon-SmithJ I Dalton
Jul 1, 1990·British Journal of Clinical Pharmacology·M J LindP M Wilkinson
Nov 1, 1990·British Journal of Clinical Pharmacology·L D LewisH J Rogers
Mar 19, 1983·British Medical Journal·D C Flenley
Nov 17, 2015·Expert Review of Anticancer Therapy·Dahlia SalmanShereen Nabhani-Gebara
Oct 15, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Odile OberlinFlorent de Vathaire
May 20, 2004·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Satoshi TakamotoMikio Yashiki
Dec 30, 1983·The American Journal of Medicine·J L Decker
Jan 1, 1994·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·W K EvansS Dahrouge
Dec 17, 2014·The American Journal of Pathology·Benoît RanchouxFrédéric Perros
Sep 3, 2014·Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners·Dahlia SalmanShereen Nabhani-Gebara
Jun 5, 1982·British Medical Journal·L E RamsayS Freestone
Mar 10, 2001·Clinical Pharmacokinetics·T KerbuschJ H Beijnen
Jan 5, 2002·Paediatric Drugs·M PaulussenH Jürgens
Aug 2, 2017·British Journal of Clinical Pharmacology·Antonio RuggieroRiccardo Riccardi
Jan 1, 1985·Critical Reviews in Toxicology·R O BeauchampH D Heck

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Bronchogenic

Bronchogenic Carcinoma is a malignant lung cancer arising in the epithelium of the bronchus or bronchiole. Discover the latest research on Bronchogenic Carcinoma here.

Cancer Metabolism

In order for cancer cells to maintain rapid, uncontrolled cell proliferation, they must acquire a source of energy. Cancer cells acquire metabolic energy from their surrounding environment and utilize the host cell nutrients to do so. Here is the latest research on cancer metabolism.